T Cell Therapy Targeted on HLA-A02 Restricted HIV Antigen Epitopes: An Open Label Cellular Therapy Trial Using CD8+ T Cell

Objective: To test the safety and efficacy of a T cell therapy de novo targeting HLA-A02 restricted HIV antigen epitopes. Design: This was a prospective open label clinical trial, which enrolled 28 HIV+ participants and 24 of them finished the trial. The study was publicly registered at Chinese Clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Sai, Sun, Jianping, Li, Zhen, Qin, Ling, Liu, Guihai, Li, Kang, Wu, Hao, Dong, Tao, Zhang, Yonghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435000/
https://www.ncbi.nlm.nih.gov/pubmed/30941124
http://dx.doi.org/10.3389/fimmu.2019.00437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435000/
https://www.ncbi.nlm.nih.gov/pubmed/30941124
http://dx.doi.org/10.3389/fimmu.2019.00437

Ejemplares similares